跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 113 条关于
“tralokinumab-ldrm”
全部
113
临床试验
87
药物
5
机构
1
资讯
20
去年
Adbry (Tralokinumab) Shows Sustained Long-Term Efficacy and Safety in Atopic Dermatitis Patients: ECZTEND Trial Results
去年
Atopic Dermatitis Market Poised for Four-Fold Growth by 2034, Driven by Novel IL-13 Inhibitor Approvals
去年
Tralokinumab Shows Sustained Efficacy and Safety in Long-Term Atopic Dermatitis Treatment
去年
LEO Pharma's Adtralza/Adbry Shows Promise in Adolescent Atopic Dermatitis Treatment
去年
LEO Pharma's Adbry Shows Sustained Efficacy in Long-Term Atopic Dermatitis Treatment
去年
Robust Pipeline of 50+ Therapies Reshaping Moderate to Severe Atopic Dermatitis Treatment Landscape
去年
Tralokinumab Demonstrates Sustained Improvement in Atopic Dermatitis Symptoms in Real-World Study
去年
LEO Pharma's Tralokinumab Meets All Endpoints in Phase 3b Hand Atopic Dermatitis Trial
去年
Tralokinumab Demonstrates Efficacy in Reducing Genital Atopic Dermatitis Severity
10个月前
Dupilumab Demonstrates Superior 2-Year Drug Survival in Atopic Dermatitis Treatment Landscape
第 1 页,共 2 页
上一页
下一页